Literature DB >> 12626904

Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.

Salvatore Pucciarelli1, Marco Agostini, Alessandra Viel, Roberta Bertorelle, Valentina Russo, Paola Toppan, Mario Lise.   

Abstract

PURPOSE: Early-age-at-onset colorectal cancer and microsatellite instability are characteristic features of hereditary nonpolyposis colorectal cancer. Our aim was therefore to investigate whether these features might be useful markers in screening for hereditary nonpolyposis colorectal cancer and mismatch repair gene mutations.
METHODS: From 1,132 consecutive patients who underwent surgery for colorectal cancer at our department between 1980 and 1999, we selected all patients 40 years of age or younger (study group, n = 59) and a subset of patients 40 years of age or older (control group, n = 60) who were matched for gender and pathologic TNM stage. Patients for whom a complete family cancer history or microsatellite status was unavailable were excluded from the study. Family cancer histories, retrieved from archival charts, were reassessed. Microsatellite status was investigated with the five microsatellites from the Bethesda recommended panel (BAT-26, BAT-25, D2S123, D5S346, and D17S250). On the basis of the number of altered microsatellites (> or = 2, 1, or 0), tumors were considered as having high or low instability or microsatellite stability, respectively. Mutation analysis for MLH1 and MSH2 genes was performed only in cases of high instability. DNA was investigated for mutations by single-strand conformational polymorphism and sequencing analysis.
RESULTS: Data from 95 patients (study group: n = 37, 18 males, mean age 35 years; control group: n = 58, 29 males, mean age 62 years) were available for analysis. Four patients (study group, n = 3; control group, n = 1) fulfilled the Amsterdam II criteria for hereditary nonpolyposis colorectal cancer. Of the 37 study group tumors, 12 (32.4 percent) showed high-frequency microsatellite instability, and 25 had microsatellite stability, whereas among the 58 control group tumors, 4 (7 percent) showed high-frequency microsatellite instability, and 54 had microsatellite stability (P < 0.002). Mismatch repair gene mutation analysis was performed in 12 cases (study group, n = 7; control group, n = 5). We found four mutations (MSH2 119delG, MLH1 ex9 684insT, MSH2 Gln239Stop, and MLH1 del0.8 Kb) in the study group patients and none in the control group. Of four hereditary nonpolyposis colorectal cancer patients who underwent mismatch repair gene mutation analysis, one had a mutation.
CONCLUSIONS: Early-age-at-onset colorectal cancer is significantly correlated with high-frequency microsatellite instability tumor status and is a useful criterion to identify hereditary nonpolyposis colorectal cancer patients. Moreover, when used in association with high-frequency microsatellite instability status, it is effective in selecting patients for mismatch repair gene mutation analysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626904     DOI: 10.1007/s10350-004-6546-9

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  13 in total

1.  Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.

Authors:  R C Niessen; M J W Berends; Y Wu; R H Sijmons; H Hollema; M J L Ligtenberg; H E K de Walle; E G E de Vries; A Karrenbeld; C H C M Buys; A G J van der Zee; R M W Hofstra; J H Kleibeuker
Journal:  Gut       Date:  2006-04-24       Impact factor: 23.059

Review 2.  Early-onset colorectal cancer: a sporadic or inherited disease?

Authors:  Vittoria Stigliano; Lupe Sanchez-Mete; Aline Martayan; Marcello Anti
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 3.  Early-onset colorectal cancer: a separate subset of colorectal cancer.

Authors:  Irene Osorio Silla; Daniel Rueda; Yolanda Rodríguez; Juan Luis García; Felipe de la Cruz Vigo; José Perea
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 4.  The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment.

Authors:  Louise C Connell; José Mauricio Mota; Maria Ignez Braghiroli; Paulo M Hoff
Journal:  Curr Treat Options Oncol       Date:  2017-04

Review 5.  Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management.

Authors:  Gregory Kouraklis; Evangelos P Misiakos
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

6.  Pedigree and genetic analysis of a novel mutation carrier patient suffering from hereditary nonpolyposis colorectal cancer.

Authors:  Miklós Tanyi; Judith Olasz; Géza Lukács; Orsolya Csuka; László Tóth; Zoltán Szentirmay; Zsuzsa Ress; Zsolt Barta; János L Tanyi; László Damjanovich
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

7.  Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers.

Authors:  E Rampazzo; R Bertorelle; L Serra; L Terrin; C Candiotto; S Pucciarelli; P Del Bianco; D Nitti; A De Rossi
Journal:  Br J Cancer       Date:  2010-04-13       Impact factor: 7.640

8.  Lynch syndrome in a predominantly Afrocentric population: a clinicopathological and genetic study.

Authors:  Joseph M Plummer; Sheray N Chin; Melyssa Aronson; Rondell P Graham; Nadia P Williams; Bharati Bapat; Gillian Wharfe; Aaron Pollett; Steven Gallinger
Journal:  Can J Surg       Date:  2012-10       Impact factor: 2.089

9.  Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer.

Authors:  Dandan Li; Fulan Hu; Fan Wang; Binbin Cui; Xinshu Dong; Wencui Zhang; Chunqing Lin; Xia Li; Da Wang; Yashuang Zhao
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

10.  Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer.

Authors:  R Bertorelle; M Briarava; E Rampazzo; L Biasini; M Agostini; I Maretto; S Lonardi; M L Friso; C Mescoli; V Zagonel; D Nitti; A De Rossi; S Pucciarelli
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.